IL-13 induces (i) mucus hypersecretion, (ii) airway fibrosis, and (iii) corticosteroid resistance, and anti-IL-13 therapies have shown some benefit in reducing exacerbations in asthma [71]. The gene discussed is IL13; the disease is asthma.